Arcutis Biotherapeutics (NasdaqGS:ARQT) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsBrian Schoelpkopf - VP of Investor RelationsDouglas Tsao - Managing DirectorFrank Watanabe - President and CEOIkenna Okafor - Biotechnology Equity ResearchLata Vyravan - CFOPatrick Burnett - CMORitch Law - VP in Global Investment ResearchSeamus Fernandez - Senior Managing DirectorSerge Belanger - Managing DirectorTodd Edwards - CCOConference Call ParticipantsJudah Frommer - Executive Director, Sen ...